Ad is loading...
FJPNX
Price
$17.23
Change
-$0.15 (-0.86%)
Updated
Nov 15 closing price
RMBPX
Price
$10.25
Change
-$0.11 (-1.06%)
Updated
Nov 15 closing price
Ad is loading...

FJPNX vs RMBPX

Header iconFJPNX vs RMBPX Comparison
Open Charts FJPNX vs RMBPXBanner chart's image
Fidelity Japan
Price$17.23
Change-$0.15 (-0.86%)
VolumeN/A
CapitalizationN/A
RMB Japan I
Price$10.25
Change-$0.11 (-1.06%)
VolumeN/A
CapitalizationN/A
FJPNX vs RMBPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FJPNX vs. RMBPX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FJPNX is a Buy and RMBPX is a Sell.

FUNDAMENTALS
Fundamentals
FJPNX has more cash in the bank: 693M vs. RMBPX (21.7M). RMBPX pays higher dividends than FJPNX: RMBPX (4.01) vs FJPNX (0.77). FJPNX was incepted earlier than RMBPX: FJPNX (32 years) vs RMBPX (7 years). RMBPX is a more actively managed with annual turnover of: 52.00 vs. FJPNX (25.00). FJPNX has a lower initial minimum investment than RMBPX: FJPNX (0) vs RMBPX (100000). FJPNX annual gain was more profitable for investors over the last year : 11.75 vs. RMBPX (10.86). RMBPX return over 5 years is better than : 12.03 vs. FJPNX (10.54).
FJPNXRMBPXFJPNX / RMBPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years7 years-
Gain YTD7.2184.592157%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets693M21.7M3,194%
Annual Yield % from dividends0.774.0119%
Returns for 1 year11.7510.86108%
Returns for 3 years-18.04-3.41529%
Returns for 5 years10.5412.0388%
Returns for 10 years53.88N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPEV12.740.11
+0.87%
XPeng
XOM119.31-1.25
-1.04%
Exxon Mobil Corp
LDTC0.32-0.01
-1.76%
LeddarTech Holdings
MYGN15.25-0.43
-2.74%
Myriad Genetics
URGN11.19-0.67
-5.65%
UroGen Pharma Ltd